– a new Life Science Venture Group in the Nordics
Eir Ventures aims to use a strong Nordic base and focus as a foundation to help leverage the power in current global medical research, thus being part in bringing innovative medicine to the patients.
Our team has strong roots and networks in the Nordic countries, exceptional industry networks, an international perspective and proven track records:
- Experts in life science investing, company creation, and technology/science evaluation.
- The team has been part in managing funds with more than €4 billion assets under management in aggregate, with more than 30 profitable exits.
- Deep experience-based approach to Life Science Venture Capital investing – from early stage as well as more mature opportunities.
- Investing in opportunities addressing significant unmet medical needs for new therapies, medical technology and digital health.
- Strong collaborations with universities and incubators in the Nordics.